Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.
astatine-211
cancer therapy
gold nanoparticles
intravenous administration
pancreatic cancer
targeted alpha-particle therapy
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
02 Dec 2022
02 Dec 2022
Historique:
received:
13
10
2022
revised:
26
11
2022
accepted:
30
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Alpha-particle radiotherapy has gained considerable attention owing to its potent anti-cancer effect.
Identifiants
pubmed: 36559199
pii: pharmaceutics14122705
doi: 10.3390/pharmaceutics14122705
pmc: PMC9782038
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : JP20H05675, JP20H00404, 22J10766
Organisme : QiSS program of the OPERA grant
ID : JPMJOP1721
Organisme : JSPS Grant-in-Aid for Scientific Research on Innovative Areas
ID : JP16H06278
Références
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1142-51
pubmed: 26884153
Nanomaterials (Basel). 2019 Apr 18;9(4):
pubmed: 31003512
J Nanobiotechnology. 2021 Jul 28;19(1):223
pubmed: 34320997
J Pharm Sci. 2021 Aug;110(8):2955-2965
pubmed: 33812886
Int J Nanomedicine. 2021 Oct 28;16:7297-7305
pubmed: 34737567
Ann Nucl Med. 2021 Jun;35(6):702-718
pubmed: 33871803
Semin Cancer Biol. 2022 Nov;86(Pt 2):1056-1065
pubmed: 34843989
Cancer Biother Radiopharm. 2020 Aug;35(6):404-417
pubmed: 32552031
Chem Rev. 2015 Oct 14;115(19):10575-636
pubmed: 26114396
Nat Mater. 2020 May;19(5):566-575
pubmed: 31932672
J Nucl Med. 2019 Sep;60(9):1301-1307
pubmed: 30796173
J Control Release. 2000 Mar 1;65(1-2):271-84
pubmed: 10699287
J Control Release. 2015 Jul 28;210:115-24
pubmed: 25980622
Mol Imaging. 2013 Sep;12(6):376-87
pubmed: 23981783
J Nanobiotechnology. 2018 Jul 11;16(1):55
pubmed: 29996877
Adv Drug Deliv Rev. 2011 Mar 18;63(3):136-51
pubmed: 20441782
Immunotherapy. 2019 Oct;11(15):1293-1302
pubmed: 31530200
Langmuir. 2013 Jul 23;29(29):9138-48
pubmed: 23815604
Nanomedicine. 2018 Jan;14(1):1-12
pubmed: 28882675
Inhal Toxicol. 2022;34(13-14):361-379
pubmed: 36053230
Ther Deliv. 2013 Apr;4(4):421-3
pubmed: 23557281
J Nucl Med. 2020 Apr;61(4):563-569
pubmed: 31586001
Curr Radiopharm. 2008 Sep 1;1(3):177
pubmed: 20150978
Cancer Sci. 2021 Mar;112(3):1132-1140
pubmed: 33277750
J Pharm Sci. 2021 Feb;110(2):888-897
pubmed: 33212161
Cancer Nanotechnol. 2016;7(1):8
pubmed: 27867425
Phys Med Biol. 2004 Aug 21;49(16):3703-12
pubmed: 15446799
Colloids Surf B Biointerfaces. 2008 Oct 15;66(2):274-80
pubmed: 18722754
Glob J Health Sci. 2015 Jul 30;8(4):1-9
pubmed: 26573043
Nucl Med Biol. 2002 Oct;29(7):729-39
pubmed: 12381453
J Biomed Nanotechnol. 2014 Mar;10(3):393-404
pubmed: 24730235
Bioconjug Chem. 2008 Oct;19(10):1951-9
pubmed: 18788773
Bioconjug Chem. 2015 Jan 21;26(1):39-50
pubmed: 25496453
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276
pubmed: 30813007
Sci Rep. 2019 Feb 21;9(1):2494
pubmed: 30792478
Curr Med Chem. 2018;25(16):1920-1944
pubmed: 29345568
Biochim Biophys Acta. 2001 Oct 1;1514(2):291-302
pubmed: 11557028
Curr Pharm Des. 2000 Sep;6(14):1433-55
pubmed: 10903402
Nanoscale. 2015 Nov 28;7(44):18584-94
pubmed: 26489965
J Nucl Med. 2016 Dec;57(12):1941-1944
pubmed: 27390158
Nanomaterials (Basel). 2020 Aug 28;10(9):
pubmed: 32872181
Int J Nanomedicine. 2015 Mar 16;10:2065-77
pubmed: 25844037
Nanoscale. 2017 Dec 21;10(1):18-33
pubmed: 29211091
Small. 2011 Jul 18;7(14):2052-60
pubmed: 21688390
J Biomed Nanotechnol. 2017 Feb;13(2):167-79
pubmed: 29377647